Osteoporosis, Paget’s Disease and Alendronate As part of the of drug family called bisphosphonates alendronate sodium works by increasing the thickness of bone by slowing down the cells that usually break down bone. This allows the cells that build bone to work more efficiently. Alendronate can help to reduce the incidence of osteoporosis-related fractures by[…]
Alendronate: Helping Bones Get Stronger
Drug Research & Development API, Osteoporosis Tags: DMFosteoporosis Mar 28, 2016
Increased Bone Mineral Density in Denosumab Data Presented at ENDO 2015
Drug Research & Development API, Monoclonal Antibodies / mAb, Osteoporosis Tags: osteoporosisvitamin D Aug 17, 2015
Exciting news was presented at ENDO 2015 regarding the use of Denosumab for osteoporosis in post-menopausal women who are at high risk for bone fractures. Results from a comprehensive trial coined Freedom showed the use of Denosumab successfully increased bone mineral density (BMD) at cortical bone sites, particularly the 1/3 radius skeletal site which does[…]
FDA Approves Bazedoxifene and Conjugated Estrogens to Treat Hot Flashes and Prevent Osteoporosis
Drug Research & Development API, Hormonal Agent, Osteoporosis Tags: osteoporosis Oct 16, 2013
On October 3, 2013 the FDA approved the new medication Duavee, comprised of Bazedoxifene and conjugated estrogens (Premarin) to treat hot flashes in postmenopausal women. The unique ability of this novel treatment to curtail hot flashes and help prevent osteoporosis is encouraging for gynecologists and their female patients who are experiencing post-menopause. The combination of[…]
Vitamin D Analogues Clinically Useful for Several Conditions
Anti-Psoriatic, Chemotherapeutic / Anti-Neoplastic, Drug Research & Development API, Hypocalcemia, Osteoporosis Tags: hypocalcemiaosteoporosisplaque psoriasisPsoriasisvitamin D May 02, 2012
Calcium regulation in the human body. The role of vitamin D is shown in orange. There are several active pharmaceutical ingredient products known as vitamin D analogues, which are derivatives of this powerful vitamin, designed to aid patients’ health and well being. Vitamin D is known by many people as the vitamin that helps to[…]
Bazedoxifene Proven Safe and Effective For Women At Risk For Osteoporosis
Drug Research & Development API, Hormonal Agent, Osteoporosis Tags: European Commissionosteoporosis May 02, 2011
A clinical study spanning two years investigated the effects of the drug Bazedoxifene (Conbriza) at 10, 20 and 40 mg on postmenopausal women at risk for osteoporosis. The results showed positive indications for preventing bone loss and reducing bone turnover. What’s more is that the study demonstrated the drug’s safety profile and its use is[…]
